Progress of molecular markers related to papillary thyroid carcinoma

Q4 Medicine

肿瘤研究与临床 Pub Date : 2020-03-28 DOI:10.3760/CMA.J.CN115355-20190814-00359

Xiaopan Li, Xi'an Lu

引用次数: 0

Abstract

Papillary thyroid carcinoma is the most common malignant tumor in the head and neck. The incidence of papillary thyroid carcinoma has been increasing in recent years. Although the prognosis of most papillary thyroid carcinoma is better, many patients have poor prognosis due to recurrence or metastasis. Molecular markers play an important role in the development, diagnosis, treatment and prognosis of papillary thyroid carcinoma. This paper reviews the progress of molecular markers related to papillary thyroid carcinoma. Key words: Thyroid neoplasms; Carcinoma, papillary; Molecular markers; Prognosis; Treatment

查看原文本刊更多论文

甲状腺乳头状癌相关分子标志物的研究进展

甲状腺乳头状癌是头颈部最常见的恶性肿瘤。甲状腺乳头状癌的发病率近年来呈上升趋势。尽管大多数甲状腺乳头状癌的预后较好，但许多患者由于复发或转移而预后不佳。分子标记物在甲状腺乳头状癌的发生、诊断、治疗和预后中起着重要作用。本文就甲状腺乳头状癌相关分子标志物的研究进展作一综述。关键词：甲状腺肿瘤；癌，乳头状；分子标记；预后；治疗

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

肿瘤研究与临床 Medicine-Oncology

CiteScore

0.10

自引率

0.00%

发文量

7737

期刊介绍： "Cancer Research and Clinic" is a series of magazines of the Chinese Medical Association under the supervision of the National Health Commission and sponsored by the Chinese Medical Association. It mainly reflects scientific research results and academic trends in the field of malignant tumors. The main columns include monographs, guidelines and consensus, standards and norms, treatises, short treatises, survey reports, reviews, clinical pathology (case) discussions, case reports, etc. The readers are middle- and senior-level medical staff engaged in basic research and clinical work on malignant tumors.